Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Caleb Naysmith

OpenAI CEO Sam Altman Says a Cure for Cancer Is Not Enough to Justify AI’s Risks, ‘We Should Set Our Sights Higher’

Sam Altman was recently asked on Bloomberg why the artificial intelligence (AI) industry has failed to convince ordinary people that any of this is good for them. He agreed that it has failed, said OpenAI is part of the problem, and then argued that the industry's most common answer to the question is not good enough, either.

"You hear some people talk about, 'Well, we're going to give you a cure for cancer, and that's so great. So we're going to take these risks and you're going to have to have less power and autonomy,'" he said. "We want people to have more power and autonomy. I don't think a cure for cancer is enough."

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.